- Report
- May 2025
- 258 Pages
Global
From €4370EUR$4,950USD£3,812GBP
- Report
- August 2025
- 180 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- July 2025
- 123 Pages
Global
From €2339EUR$2,650USD£2,041GBP
- Report
- August 2025
- 198 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- August 2025
- 197 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- August 2025
- 194 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$4,247USD£3,160GBP
The Grignard Reagent market is a key component of the Drug Discovery industry. Grignard Reagents are organometallic compounds used in organic synthesis, and are essential for the development of new drugs. They are used to synthesize a wide range of compounds, including pharmaceuticals, agrochemicals, and specialty chemicals. Grignard Reagents are also used in the production of polymers, dyes, and other materials.
The Grignard Reagent market is highly competitive, with a number of major players offering a range of products. Companies in the market include Sigma-Aldrich, Merck, Alfa Aesar, Strem Chemicals, and Acros Organics. Show Less Read more